Article
Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and management.
Leukemia & lymphoma - 1 Feb 2024
Tharakan Serena, Mascarenhas John, Tremblay Douglas
Abstract excerpt
ABSTRACTMyeloproliferative neoplasms (MPNs) that lack the classical "driver mutations," termed triple negative MPNs, remain a poorly understood entity. Despite considerable progress toward understanding MPN pathobiology, the mechanisms leading to the development of these MPNs remains inadequately elucidated. While triple negative primary myelofibrosis (TN-PMF) portends a poor prognosis, triple negative essential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
